The identified anti‐Parkinsonian medications (e.g., levodopa, dopamine agonists, MAO‐B inhibitors) lack specificity for PD, as they are also indicated for other movement disorders (such as essential tremor [ET] and restless legs syndrome [RLS]) or non‐movement disorder conditions. This evidence concerns the gene MAOB and essential thrombocythemia.